Pioglitazone-mediated changes in lipoprotein particle composition are predicted by changes in adiponectin level in type 2 diabetes.
暂无分享,去创建一个
[1] E. Ding,et al. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. , 2009, JAMA.
[2] J. Frystyk,et al. Adiponectin and Lipoprotein Particle Size , 2009, Diabetes Care.
[3] G. Watts,et al. Very low density lipoprotein metabolism and plasma adiponectin as predictors of high-density lipoprotein apolipoprotein A-I kinetics in obese and nonobese men. , 2009, The Journal of clinical endocrinology and metabolism.
[4] Philip A Kern,et al. Adipocytokines and the metabolic complications of obesity. , 2008, The Journal of clinical endocrinology and metabolism.
[5] Alfonso T. Perez,et al. Relationship of Abdominal Visceral and Subcutaneous Adipose Tissue With Lipoprotein Particle Number and Size in Type 2 Diabetes , 2008, Diabetes.
[6] Alfonso T. Perez,et al. Increased High-Density Lipoprotein Cholesterol Predicts the Pioglitazone-Mediated Reduction of Carotid Intima-Media Thickness Progression in Patients With Type 2 Diabetes Mellitus , 2008, Circulation.
[7] S. Kihara,et al. Adiponectin deficiency suppresses ABCA1 expression and ApoA‐I synthesis in the liver , 2007 .
[8] S. Haffner,et al. Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial. , 2006, JAMA.
[9] P. Gambert,et al. Adiponectin Is an Important Determinant of ApoA-I Catabolism , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[10] T. Kadowaki,et al. Adiponectin and adiponectin receptors. , 2005, Endocrine reviews.
[11] E. Rimm,et al. Adiponectin and future coronary heart disease events among men with type 2 diabetes. , 2005, Diabetes.
[12] R. Turner,et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.
[13] A. Jenkins,et al. Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. , 2003, Diabetes.